APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Icosapent Ethyl Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Icosapent Ethyl Drugs Industry Growth and Trends Forecast to 2032

Report ID 174001380128 December 2025118 pages

Choose your research edition.

Industry ResearchIcosapent Ethyl Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Icosapent Ethyl Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Icosapent Ethyl Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icosapent Ethyl Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Icosapent Ethyl Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Icosapent Ethyl Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Icosapent Ethyl Drugs include Sichuan Gowell Pharmaceutical, Humanwell Puracap Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical, Chengdu Suncadia Medicine, Zydus, Woodward Pharma, Teva and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Icosapent Ethyl Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Icosapent Ethyl Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Icosapent Ethyl Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Icosapent Ethyl Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Icosapent Ethyl Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Icosapent Ethyl Drugs Market by Company

Sichuan Gowell Pharmaceutical

Humanwell Puracap Pharmaceuticals

Qilu Pharmaceutical

Jiangsu Wangao Pharmaceutical

Chengdu Suncadia Medicine

Zydus

Woodward Pharma

Teva

Sun Pharma

Strides Pharma

PuraCap Pharmaceuticals

Mankind Pharma

Hikma

GLW Pharma

Dr. Reddy's Laboratories

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Amarin Pharmaceuticals

Icosapent Ethyl Drugs Segment by Type

Single Drug

Combination Drug

Icosapent Ethyl Drugs Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Icosapent Ethyl Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icosapent Ethyl Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icosapent Ethyl Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icosapent Ethyl Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Icosapent Ethyl Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Icosapent Ethyl Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Drug Table 2. Major Company of Combination Drug Table 3. Global Icosapent Ethyl Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Icosapent Ethyl Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Icosapent Ethyl Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Icosapent Ethyl Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Icosapent Ethyl Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Icosapent Ethyl Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Icosapent Ethyl Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Icosapent Ethyl Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Icosapent Ethyl Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Icosapent Ethyl Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Icosapent Ethyl Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Icosapent Ethyl Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Icosapent Ethyl Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Icosapent Ethyl Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Icosapent Ethyl Drugs Industry Trends Table 25. Icosapent Ethyl Drugs Industry Drivers Table 26. Icosapent Ethyl Drugs Industry Opportunities and Challenges Table 27. Icosapent Ethyl Drugs Industry Restraints Table 28. Global Icosapent Ethyl Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Icosapent Ethyl Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Icosapent Ethyl Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Icosapent Ethyl Drugs Sales Share by Company (2021-2026) Table 32. Global Icosapent Ethyl Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Icosapent Ethyl Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Icosapent Ethyl Drugs Major Company Production Sites and Headquarters Table 35. Global Icosapent Ethyl Drugs Company, Product Type & Application Table 36. Global Icosapent Ethyl Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Icosapent Ethyl Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Icosapent Ethyl Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Icosapent Ethyl Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Icosapent Ethyl Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Icosapent Ethyl Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Icosapent Ethyl Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Icosapent Ethyl Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Icosapent Ethyl Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Icosapent Ethyl Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Icosapent Ethyl Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Icosapent Ethyl Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Icosapent Ethyl Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Icosapent Ethyl Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Icosapent Ethyl Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Icosapent Ethyl Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Icosapent Ethyl Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Icosapent Ethyl Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Icosapent Ethyl Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Icosapent Ethyl Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Icosapent Ethyl Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Icosapent Ethyl Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Icosapent Ethyl Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Icosapent Ethyl Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Icosapent Ethyl Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Sichuan Gowell Pharmaceutical Company Information Table 72. Sichuan Gowell Pharmaceutical Business Overview Table 73. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 75. Sichuan Gowell Pharmaceutical Recent Development Table 76. Humanwell Puracap Pharmaceuticals Company Information Table 77. Humanwell Puracap Pharmaceuticals Business Overview Table 78. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 80. Humanwell Puracap Pharmaceuticals Recent Development Table 81. Qilu Pharmaceutical Company Information Table 82. Qilu Pharmaceutical Business Overview Table 83. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 85. Qilu Pharmaceutical Recent Development Table 86. Jiangsu Wangao Pharmaceutical Company Information Table 87. Jiangsu Wangao Pharmaceutical Business Overview Table 88. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 90. Jiangsu Wangao Pharmaceutical Recent Development Table 91. Chengdu Suncadia Medicine Company Information Table 92. Chengdu Suncadia Medicine Business Overview Table 93. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio Table 95. Chengdu Suncadia Medicine Recent Development Table 96. Zydus Company Information Table 97. Zydus Business Overview Table 98. Zydus Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Zydus Icosapent Ethyl Drugs Product Portfolio Table 100. Zydus Recent Development Table 101. Woodward Pharma Company Information Table 102. Woodward Pharma Business Overview Table 103. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Woodward Pharma Icosapent Ethyl Drugs Product Portfolio Table 105. Woodward Pharma Recent Development Table 106. Teva Company Information Table 107. Teva Business Overview Table 108. Teva Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Teva Icosapent Ethyl Drugs Product Portfolio Table 110. Teva Recent Development Table 111. Sun Pharma Company Information Table 112. Sun Pharma Business Overview Table 113. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sun Pharma Icosapent Ethyl Drugs Product Portfolio Table 115. Sun Pharma Recent Development Table 116. Strides Pharma Company Information Table 117. Strides Pharma Business Overview Table 118. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Strides Pharma Icosapent Ethyl Drugs Product Portfolio Table 120. Strides Pharma Recent Development Table 121. PuraCap Pharmaceuticals Company Information Table 122. PuraCap Pharmaceuticals Business Overview Table 123. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 125. PuraCap Pharmaceuticals Recent Development Table 126. Mankind Pharma Company Information Table 127. Mankind Pharma Business Overview Table 128. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Mankind Pharma Icosapent Ethyl Drugs Product Portfolio Table 130. Mankind Pharma Recent Development Table 131. Hikma Company Information Table 132. Hikma Business Overview Table 133. Hikma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Hikma Icosapent Ethyl Drugs Product Portfolio Table 135. Hikma Recent Development Table 136. GLW Pharma Company Information Table 137. GLW Pharma Business Overview Table 138. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. GLW Pharma Icosapent Ethyl Drugs Product Portfolio Table 140. GLW Pharma Recent Development Table 141. Dr. Reddy's Laboratories Company Information Table 142. Dr. Reddy's Laboratories Business Overview Table 143. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio Table 145. Dr. Reddy's Laboratories Recent Development Table 146. Ascent Pharmaceuticals Company Information Table 147. Ascent Pharmaceuticals Business Overview Table 148. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 150. Ascent Pharmaceuticals Recent Development Table 151. Apotex Company Information Table 152. Apotex Business Overview Table 153. Apotex Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Apotex Icosapent Ethyl Drugs Product Portfolio Table 155. Apotex Recent Development Table 156. Amneal Pharmaceuticals Company Information Table 157. Amneal Pharmaceuticals Business Overview Table 158. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 160. Amneal Pharmaceuticals Recent Development Table 161. Amarin Pharmaceuticals Company Information Table 162. Amarin Pharmaceuticals Business Overview Table 163. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 165. Amarin Pharmaceuticals Recent Development Table 166. North America Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. North America Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 168. North America Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026) Table 169. North America Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 170. North America Icosapent Ethyl Drugs Sales Market Share Forecast by Country (2027-2032) Table 171. North America Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Icosapent Ethyl Drugs Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Icosapent Ethyl Drugs Market Share by Country (2021-2026) Table 174. North America Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Icosapent Ethyl Drugs Market Share Forecast by Country (2027-2032) Table 176. Europe Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Europe Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 178. Europe Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026) Table 179. Europe Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 180. Europe Icosapent Ethyl Drugs Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Icosapent Ethyl Drugs Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Icosapent Ethyl Drugs Market Share by Country (2021-2026) Table 184. Europe Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Icosapent Ethyl Drugs Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 188. Asia-Pacific Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 190. Asia-Pacific Icosapent Ethyl Drugs Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Icosapent Ethyl Drugs Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Icosapent Ethyl Drugs Market Share by Country (2021-2026) Table 194. Asia-Pacific Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Icosapent Ethyl Drugs Market Share Forecast by Country (2027-2032) Table 196. Latin America Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Latin America Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 198. Latin America Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026) Table 199. Latin America Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 200. Latin America Icosapent Ethyl Drugs Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Icosapent Ethyl Drugs Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Icosapent Ethyl Drugs Market Share by Country (2021-2026) Table 204. Latin America Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Icosapent Ethyl Drugs Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 208. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 210. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Icosapent Ethyl Drugs Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Icosapent Ethyl Drugs Market Share by Country (2021-2026) Table 214. Middle East and Africa Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Icosapent Ethyl Drugs Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Icosapent Ethyl Drugs Distributors List Table 219. Icosapent Ethyl Drugs Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Icosapent Ethyl Drugs Image Figure 2. Global Icosapent Ethyl Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icosapent Ethyl Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Icosapent Ethyl Drugs Sales (2021-2032) & (K Units) Figure 5. Single Drug Image Figure 6. Global Single Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Drug Image Figure 8. Global Combination Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Icosapent Ethyl Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Icosapent Ethyl Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Icosapent Ethyl Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Icosapent Ethyl Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Icosapent Ethyl Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Icosapent Ethyl Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Icosapent Ethyl Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Icosapent Ethyl Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Icosapent Ethyl Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Icosapent Ethyl Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Icosapent Ethyl Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacy Image Figure 24. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Online Pharmacy Image Figure 26. Global Online Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Icosapent Ethyl Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Icosapent Ethyl Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Icosapent Ethyl Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Icosapent Ethyl Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Icosapent Ethyl Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Icosapent Ethyl Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Icosapent Ethyl Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Icosapent Ethyl Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Icosapent Ethyl Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Icosapent Ethyl Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Icosapent Ethyl Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Icosapent Ethyl Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Icosapent Ethyl Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Icosapent Ethyl Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Icosapent Ethyl Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Icosapent Ethyl Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Icosapent Ethyl Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Icosapent Ethyl Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Icosapent Ethyl Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Icosapent Ethyl Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Icosapent Ethyl Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Icosapent Ethyl Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Icosapent Ethyl Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Icosapent Ethyl Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Icosapent Ethyl Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Icosapent Ethyl Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Icosapent Ethyl Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Icosapent Ethyl Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Drug
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Sichuan Gowell Pharmaceutical
  • Humanwell Puracap Pharmaceuticals
  • Qilu Pharmaceutical
  • Jiangsu Wangao Pharmaceutical
  • Chengdu Suncadia Medicine
  • Zydus
  • Woodward Pharma
  • Teva
  • Sun Pharma
  • Strides Pharma
  • PuraCap Pharmaceuticals
  • Mankind Pharma
  • Hikma
  • GLW Pharma
  • Dr. Reddy's Laboratories
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Amarin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Icosapent Ethyl Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Icosapent Ethyl Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Icosapent Ethyl Drugs Market by Type
  6. 1.3.1 Single Drug
  7. 1.3.2 Combination Drug
  8. 1.4 Global Icosapent Ethyl Drugs Market Size by Type
  9. 1.4.1 Global Icosapent Ethyl Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Icosapent Ethyl Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Icosapent Ethyl Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Icosapent Ethyl Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Icosapent Ethyl Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Icosapent Ethyl Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Icosapent Ethyl Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Icosapent Ethyl Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Icosapent Ethyl Drugs Industry Trends
  2. 2.2 Icosapent Ethyl Drugs Industry Drivers
  3. 2.3 Icosapent Ethyl Drugs Industry Opportunities and Challenges
  4. 2.4 Icosapent Ethyl Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Icosapent Ethyl Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Icosapent Ethyl Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Icosapent Ethyl Drugs Price (2021-2026)
  4. 3.4 Global Icosapent Ethyl Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Icosapent Ethyl Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Icosapent Ethyl Drugs Company, Product Type & Application
  7. 3.7 Global Icosapent Ethyl Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Icosapent Ethyl Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Icosapent Ethyl Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Icosapent Ethyl Drugs Tier 1, Tier 2, and Tier 3
4 Icosapent Ethyl Drugs Regional Status and Outlook
  1. 4.1 Global Icosapent Ethyl Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Icosapent Ethyl Drugs Historic Market Size by Region
  3. 4.2.1 Global Icosapent Ethyl Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Icosapent Ethyl Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Icosapent Ethyl Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Icosapent Ethyl Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Icosapent Ethyl Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Icosapent Ethyl Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Icosapent Ethyl Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Icosapent Ethyl Drugs by Application
  1. 5.1 Icosapent Ethyl Drugs Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Icosapent Ethyl Drugs Market Size by Application
  6. 5.2.1 Global Icosapent Ethyl Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Icosapent Ethyl Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Icosapent Ethyl Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Icosapent Ethyl Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Icosapent Ethyl Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Icosapent Ethyl Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Icosapent Ethyl Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Icosapent Ethyl Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sichuan Gowell Pharmaceutical
  2. 6.1.1 Sichuan Gowell Pharmaceutical Company Information
  3. 6.1.2 Sichuan Gowell Pharmaceutical Business Overview
  4. 6.1.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  6. 6.1.5 Sichuan Gowell Pharmaceutical Recent Developments
  7. 6.2 Humanwell Puracap Pharmaceuticals
  8. 6.2.1 Humanwell Puracap Pharmaceuticals Company Information
  9. 6.2.2 Humanwell Puracap Pharmaceuticals Business Overview
  10. 6.2.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  12. 6.2.5 Humanwell Puracap Pharmaceuticals Recent Developments
  13. 6.3 Qilu Pharmaceutical
  14. 6.3.1 Qilu Pharmaceutical Company Information
  15. 6.3.2 Qilu Pharmaceutical Business Overview
  16. 6.3.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  18. 6.3.5 Qilu Pharmaceutical Recent Developments
  19. 6.4 Jiangsu Wangao Pharmaceutical
  20. 6.4.1 Jiangsu Wangao Pharmaceutical Company Information
  21. 6.4.2 Jiangsu Wangao Pharmaceutical Business Overview
  22. 6.4.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  24. 6.4.5 Jiangsu Wangao Pharmaceutical Recent Developments
  25. 6.5 Chengdu Suncadia Medicine
  26. 6.5.1 Chengdu Suncadia Medicine Company Information
  27. 6.5.2 Chengdu Suncadia Medicine Business Overview
  28. 6.5.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio
  30. 6.5.5 Chengdu Suncadia Medicine Recent Developments
  31. 6.6 Zydus
  32. 6.6.1 Zydus Company Information
  33. 6.6.2 Zydus Business Overview
  34. 6.6.3 Zydus Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zydus Icosapent Ethyl Drugs Product Portfolio
  36. 6.6.5 Zydus Recent Developments
  37. 6.7 Woodward Pharma
  38. 6.7.1 Woodward Pharma Company Information
  39. 6.7.2 Woodward Pharma Business Overview
  40. 6.7.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Woodward Pharma Icosapent Ethyl Drugs Product Portfolio
  42. 6.7.5 Woodward Pharma Recent Developments
  43. 6.8 Teva
  44. 6.8.1 Teva Company Information
  45. 6.8.2 Teva Business Overview
  46. 6.8.3 Teva Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Icosapent Ethyl Drugs Product Portfolio
  48. 6.8.5 Teva Recent Developments
  49. 6.9 Sun Pharma
  50. 6.9.1 Sun Pharma Company Information
  51. 6.9.2 Sun Pharma Business Overview
  52. 6.9.3 Sun Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharma Icosapent Ethyl Drugs Product Portfolio
  54. 6.9.5 Sun Pharma Recent Developments
  55. 6.10 Strides Pharma
  56. 6.10.1 Strides Pharma Company Information
  57. 6.10.2 Strides Pharma Business Overview
  58. 6.10.3 Strides Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Strides Pharma Icosapent Ethyl Drugs Product Portfolio
  60. 6.10.5 Strides Pharma Recent Developments
  61. 6.11 PuraCap Pharmaceuticals
  62. 6.11.1 PuraCap Pharmaceuticals Company Information
  63. 6.11.2 PuraCap Pharmaceuticals Business Overview
  64. 6.11.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  66. 6.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 6.12 Mankind Pharma
  68. 6.12.1 Mankind Pharma Company Information
  69. 6.12.2 Mankind Pharma Business Overview
  70. 6.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Mankind Pharma Icosapent Ethyl Drugs Product Portfolio
  72. 6.12.5 Mankind Pharma Recent Developments
  73. 6.13 Hikma
  74. 6.13.1 Hikma Company Information
  75. 6.13.2 Hikma Business Overview
  76. 6.13.3 Hikma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hikma Icosapent Ethyl Drugs Product Portfolio
  78. 6.13.5 Hikma Recent Developments
  79. 6.14 GLW Pharma
  80. 6.14.1 GLW Pharma Company Information
  81. 6.14.2 GLW Pharma Business Overview
  82. 6.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 GLW Pharma Icosapent Ethyl Drugs Product Portfolio
  84. 6.14.5 GLW Pharma Recent Developments
  85. 6.15 Dr. Reddy's Laboratories
  86. 6.15.1 Dr. Reddy's Laboratories Company Information
  87. 6.15.2 Dr. Reddy's Laboratories Business Overview
  88. 6.15.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio
  90. 6.15.5 Dr. Reddy's Laboratories Recent Developments
  91. 6.16 Ascent Pharmaceuticals
  92. 6.16.1 Ascent Pharmaceuticals Company Information
  93. 6.16.2 Ascent Pharmaceuticals Business Overview
  94. 6.16.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  96. 6.16.5 Ascent Pharmaceuticals Recent Developments
  97. 6.17 Apotex
  98. 6.17.1 Apotex Company Information
  99. 6.17.2 Apotex Business Overview
  100. 6.17.3 Apotex Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Apotex Icosapent Ethyl Drugs Product Portfolio
  102. 6.17.5 Apotex Recent Developments
  103. 6.18 Amneal Pharmaceuticals
  104. 6.18.1 Amneal Pharmaceuticals Company Information
  105. 6.18.2 Amneal Pharmaceuticals Business Overview
  106. 6.18.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  108. 6.18.5 Amneal Pharmaceuticals Recent Developments
  109. 6.19 Amarin Pharmaceuticals
  110. 6.19.1 Amarin Pharmaceuticals Company Information
  111. 6.19.2 Amarin Pharmaceuticals Business Overview
  112. 6.19.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  114. 6.19.5 Amarin Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Icosapent Ethyl Drugs Sales by Country
  2. 7.1.1 North America Icosapent Ethyl Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Icosapent Ethyl Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Icosapent Ethyl Drugs Market Size by Country
  6. 7.2.1 North America Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Icosapent Ethyl Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Icosapent Ethyl Drugs Sales by Country
  2. 8.1.1 Europe Icosapent Ethyl Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Icosapent Ethyl Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Icosapent Ethyl Drugs Market Size by Country
  6. 8.2.1 Europe Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Icosapent Ethyl Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Icosapent Ethyl Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Icosapent Ethyl Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Icosapent Ethyl Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Icosapent Ethyl Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Icosapent Ethyl Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Icosapent Ethyl Drugs Sales by Country
  2. 10.1.1 South America Icosapent Ethyl Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Icosapent Ethyl Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Icosapent Ethyl Drugs Market Size by Country
  6. 10.2.1 South America Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Icosapent Ethyl Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Icosapent Ethyl Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Icosapent Ethyl Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Icosapent Ethyl Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Icosapent Ethyl Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Icosapent Ethyl Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Icosapent Ethyl Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Icosapent Ethyl Drugs Value Chain Analysis
  2. 12.1.1 Icosapent Ethyl Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Icosapent Ethyl Drugs Production Mode & Process
  7. 12.2 Icosapent Ethyl Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Icosapent Ethyl Drugs Distributors
  10. 12.2.3 Icosapent Ethyl Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst